Information Provided By: 
Fly News Breaks for August 9, 2017
AZN
Aug 9, 2017 | 06:16 EDT
Piper Jaffray analyst Richard Purkiss believes the recent negative MYSTIC update from AstraZeneca has created a long-term buying opportunity. 2017 marks an earnings trough year for the company, and the shares now trade at discounted valuation, Purkiss tells investors in a research note. He reiterates an Overweight rating on the shares with a GBP 51 price target.
News For AZN From the Last 2 Days
AZN
Apr 18, 2024 | 09:41 EDT
Unusual total active option classes on open include: Wrap Technologies (WRAP), AstraZeneca (AZN), JetBlue (JBLU), United Continental (UAL), Taiwan Semi (TSM), Nokia (NOK), EBay (EBAY), Maplebear Inc (CART), Airbnb (ABNB), and UnitedHealth (UNH).
AZN
Apr 16, 2024 | 12:49 EDT
AZN
Apr 16, 2024 | 07:12 EDT
